Cambridge Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.99M | Buy |
11,786
+18
| +0.2% | +$4.2K | 0.51% | 34 |
|
|
2026
Q1 | $2.88M | Sell |
11,768
-20
| -0.2% | -$4.66K | 0.56% | 32 |
|
|
2025
Q4 | $2.44M | Sell |
11,788
-240
| -2% | -$47.5K | 0.46% | 37 |
|
|
2025
Q3 | $2.23M | Sell |
12,028
-89
| -0.7% | -$15.2K | 0.44% | 38 |
|
|
2025
Q2 | $1.85M | Sell |
12,117
-287
| -2% | -$44.1K | 0.39% | 42 |
|
|
2025
Q1 | $2.06M | Buy |
12,404
+11
| +0.1% | +$1.72K | 0.45% | 37 |
|
|
2024
Q4 | $1.79M | Sell |
12,393
-703
| -5% | -$109K | 0.4% | 41 |
|
|
2024
Q3 | $2.12M | Buy |
13,096
+10
| +0.1% | +$1.59K | 0.46% | 37 |
|
|
2024
Q2 | $1.91M | Sell |
13,086
-438
| -3% | -$65.1K | 0.44% | 38 |
|
|
2024
Q1 | $2.14M | Sell |
13,524
-301
| -2% | -$47.9K | 0.5% | 36 |
|
|
2023
Q4 | $2.17M | Sell |
13,825
-328
| -2% | -$50.3K | 0.54% | 32 |
|
|
2023
Q3 | $2.2M | Sell |
14,153
-352
| -2% | -$58.1K | 0.59% | 32 |
|
|
2023
Q2 | $2.4M | Sell |
14,505
-1,208
| -8% | -$195K | 0.61% | 27 |
|
|
2023
Q1 | $2.44M | Sell |
15,713
-62
| -0.4% | -$10K | 0.62% | 26 |
|
|
2022
Q4 | $2.79M | Buy |
15,775
+74
| +0.5% | +$12.8K | 0.75% | 24 |
|
|
2022
Q3 | $2.56M | Sell |
15,701
-265
| -2% | -$44.8K | 0.74% | 24 |
|
|
2022
Q2 | $2.83M | Sell |
15,966
-114
| -0.7% | -$20.3K | 0.77% | 21 |
|
|
2022
Q1 | $2.85M | Buy |
16,080
+40
| +0.2% | +$6.81K | 0.68% | 23 |
|
|
2021
Q4 | $2.74M | Buy |
16,040
+12
| +0.1% | +$1.97K | 0.62% | 24 |
|
|
2021
Q3 | $2.59M | Sell |
16,028
-90
| -0.6% | -$15.4K | 0.63% | 25 |
|
|
2021
Q2 | $2.65M | Sell |
16,118
-329
| -2% | -$54.5K | 0.64% | 25 |
|
|
2021
Q1 | $2.7M | Buy |
16,447
+9
| +0.1% | +$1.46K | 0.69% | 25 |
|
|
2020
Q4 | $2.59M | Buy |
16,438
+9
| +0.1% | +$1.33K | 0.7% | 24 |
|
|
2020
Q3 | $2.45M | Sell |
16,429
-6
| -0% | -$888 | 0.72% | 24 |
|
|
2020
Q2 | $2.31M | Sell |
16,435
-1,640
| -9% | -$239K | 0.72% | 23 |
|
|
2020
Q1 | $2.37M | Sell |
18,075
-259
| -1% | -$36.7K | 0.86% | 19 |
|
|
2019
Q4 | $2.67M | Sell |
18,334
-159
| -0.9% | -$21.6K | 0.82% | 20 |
|
|
2019
Q3 | $2.39M | Sell |
18,493
-368
| -2% | -$48.5K | 0.79% | 18 |
|
|
2019
Q2 | $2.63M | Sell |
18,861
-2,760
| -13% | -$382K | 0.87% | 19 |
|
|
2019
Q1 | $3.02M | Sell |
21,621
-815
| -4% | -$109K | 1.03% | 17 |
|
|
2018
Q4 | $2.9M | Buy |
22,436
+78
| +0.3% | +$10.9K | 1.08% | 17 |
|
|
2018
Q3 | $3.09M | Sell |
22,358
-805
| -3% | -$107K | 1.04% | 17 |
|
|
2018
Q2 | $2.81M | Sell |
23,163
-167
| -0.7% | -$20.8K | 0.99% | 17 |
|
|
2018
Q1 | $2.99M | Buy |
23,330
+831
| +4% | +$112K | 1.07% | 17 |
|
|
2017
Q4 | $3.14M | Sell |
22,499
-288
| -1% | -$40.1K | 1.13% | 16 |
|
|
2017
Q3 | $2.96M | Sell |
22,787
-189
| -0.8% | -$25.1K | 1.14% | 18 |
|
|
2017
Q2 | $3.04M | Sell |
22,976
-1,183
| -5% | -$151K | 1.23% | 17 |
|
|
2017
Q1 | $3.01M | Sell |
24,159
-164
| -0.7% | -$19.6K | 1.24% | 16 |
|
|
2016
Q4 | $2.8M | Buy |
24,323
+1,170
| +5% | +$135K | 1.24% | 15 |
|
|
2016
Q3 | $2.73M | Buy |
23,153
+63
| +0.3% | +$7.64K | 1.21% | 15 |
|
|
2016
Q2 | $2.8M | Sell |
23,090
-1,247
| -5% | -$142K | 1.28% | 15 |
|
|
2016
Q1 | $2.63M | Sell |
24,337
-377
| -2% | -$39K | 1.22% | 14 |
|
|
2015
Q4 | $2.54M | Sell |
24,714
-1,139
| -4% | -$115K | 1.44% | 15 |
|
|
2015
Q3 | $2.41M | Buy |
25,853
+1,375
| +6% | +$133K | 1.43% | 14 |
|
|
2015
Q2 | $2.39M | Sell |
24,478
-19,449
| -44% | -$1.95M | 1.34% | 15 |
|
|
2015
Q1 | $2.22M | Buy |
43,927
+19,503
| +80% | +$1.98M | 1.29% | 17 |
|
|
2014
Q4 | $2.55M | Buy |
+24,424
| New | +$2.57M | 1.56% | 15 |
|
Other funds holding JNJ
PAM
WT
CGI
Cambridge Advisors's JNJ Position: Q2 2026 in Review
Cambridge Advisors increased its Johnson & Johnson (JNJ) stake by 0.15% in Q2 2026, buying an estimated $4.2K and bringing the position to 11,786 shares worth $2.99M. The position accounts for 0.51% of the portfolio, ranked #34.
Cambridge Advisors first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $3.14M in Q4 2017. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Cambridge Advisors held 11,786 shares of Johnson & Johnson worth $2.99M as of Q2 2026.
- Cambridge Advisors bought 18 Johnson & Johnson shares in Q2 2026, an estimated $4.2K.
- Johnson & Johnson made up 0.51% of Cambridge Advisors's portfolio in Q2 2026, its #34 holding.
- Cambridge Advisors first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
- Cambridge Advisors's Johnson & Johnson position peaked at $3.14M in Q4 2017.
- 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Cambridge Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.